2 results
Approved WMOWill not start
To assess the safety and tolerability profile of durvalumab monotherapy, durvalumab + novel oncology therapy, durvalumab + chemotherapy, anddurvalumab + novel oncology therapy + chemotherapy combinations
Approved WMORecruiting
To study the safety and efficacy of deferasirox as treatment of oxidative stress in adult subjects with sickle cell disease.